MDNAF trade ideas

OTCMarketsExpert

Company Profile Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company which engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in...

Cryptonightowl

MY analysis of bullish trend for MDNA. SELL AT 2.11 ON NOVEMBER 20 in my opinion there will be a retracement.

OTCMarketsExpert

COMPANY PROFILE Medicenna Therapeutics Corp. is a clinical stage immunotherapy company, which engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in...